Global Aptamer Market

• Posted by manisha kashid March 22, 2021 - Filed in Bitcoin - #Aptamer Market  - 142 views

   Global Aptamer market was valued $xx Mn in 2020 and is expected to reach $xx Mn by 2026, at a CAGR of xx%.

  Aptamers are synthetic single-stranded DNA or RNA sequences selected from combinatorial oligonucleotide libraries through the well-known in vitro selection and iteration process, SELEX. The last three decades have witnessed a sudden boom in aptamer research, owing to their unique characteristics, like high specificity and binding affinity, low immunogenicity and toxicity, and ease in synthesis with negligible batch-to-batch variation.

  Increasing use of aptamers in drug discovery and disease treatment is expected to influence the market positively in the forecast period. Other factors, such as the use of RNA aptamers have proven to be of high therapeutic and diagnostic value with recent FDA approval of the first aptamers drug and additional ones in the clinical pipelines eventually lead to the growth of aptamers market.

  Ongoing research & development activities have led to the adoption of aptamers, both, as drugs and drug-carriers, and their application as diagnostics tools is providing new growth opportunities for manufacturers. In future, the application of aptamers will meet an expanded scope in the food and beverage industry as biosensors to ensure the quality of products. In addition, there has been tremendous growth in number of companies exploring the potential of this molecule across a diverse area of medical applications.

  Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, patent expiration of the systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the market. The increased applications of aptamers in the food and chemicals industries will provide opportunities for market growth.

  The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in Gene Therapy Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.

  The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
  Global Aptamer market Segment Analysis

  By type, the nucleic acid segment is expected to grow at a CAGR of xx% during the forecast period. Better thermodynamic and chemical stability of nucleic acid aptamers compared to peptide therapeutics have helped this segment capture large revenue share. In addition, R&D of nucleic acid aptamers is constantly increasing for the purpose of therapeutic indication.

  Based on technology, SELEX was valued $xx Mn in 2020, and is expected to reach $xx Mn by 2026. Small organic molecules are challenging targets for an aptamer selection using the SELEX technology (SELEX—Systematic Evolution of Ligans by EXponential enrichment). The Capture-SELEX procedure allows the selection of DNA aptamers for solute targets. A special SELEX library was constructed with the aim to immobilize this library on magnetic beads or other surfaces. These advancements in the SELEX methods are boosting the segment growth.

  

  Global Aptamer Market

  To know about the Research Methodology :- Request Free Sample Report
  Global Aptamer market Regional Insights

  

  Global Aptamer Market1

   

  North America accounted for the largest market share of 55% in 2020 and is expected to grow a CAGR of xx% in the forecast period. Growth in insurance coverage, presence of centres and institutes engaged in R&D and government funding are up surging the North American gene therapy market.Well-established healthcare infrastructure, ease of availability is also a key driver affecting the market growth.

  Investments by key players in this field has boosted the market growth. Rising adoption of technologically advanced diagnostic imaging systems for gene therapy is rapidly growing the market. Europe is also expected to drive the market and thefactors responsible for growth are the growing acceptance of emerging aptamer technologies, rising incidence of chronic diseases, and increasing demand for aptamer-based therapeutics in European countries.

  Asia Pacific is also expected to witness significant growth during the forecast period due to rising health care expenditures. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand.

  For more information of visit:https://www.maximizemarketresearch.com/market-report/global-aptamer-market/85295/
  Scope of the Global Aptamer market :Inquire before Buying

  

  Global Aptamer Market2
  Global Aptamer market, By Region

  • North America
  • Europe
  • South America
  • MEA
  • Asia Pacific
  Key Players Operating in the Global Aptamer Market

  • Aptamer Group
  • Aptamer Sciences, Inc.
  • Base Pair Biotechnologies, Inc.
  • NOXXON Pharma
  • SomaLogic, Inc.
  • Ophthotech Corporation
  • AM Biotechnologies, LLC
  • Aptagen, LLC (U.S.)
  • Aptamer Solutions
  • Aptus Biotech S.L
  • Base Pair Biotechnologies, Inc.
  • NeoVentures Biotechnology, Inc.
  • SomaLogic, Inc.
  • TriLinkBioTechnologies, Inc.
  • Vivonics Inc.

  The report also helps in understanding Global Aptamer Market dynamics, structure by analysing the market segments and project the Global Aptamer Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Aptamer Marketmake the report investor’s guide.

  This Report Is Submitted By : Maximize Market Research Company

  Customization of the report:

  Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

  About Maximize Market Research:

  Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.